Research Library — Mechanism & Pharmacology — Page 2 | Reta Compare
49 research articles in Mechanism & Pharmacology. Page 2 of 2.
Articles
- Exploring Retatrutide's Role in Addressing Obesity, NAFLD, and Cardiovascular Diseases
- Exploring Retatrutide: A Triple Agonist in Type 2 Diabetes Management
- Exploring the Triple Agonism of Retatrutide at GLP-1R, GIPR, and GCGR
- Exploring the Role of Retatrutide in Gut Hormone-Mediated Appetite Regulation
- Exploring the Role of Retatrutide in Managing Rare Genetic Obesity in Youth
- Exploring Retatrutide: Insights from Recent Advances in Obesity Pharmacotherapy
- Retatrutide's Role in Treating NAFLD and MASLD: Insights from Recent Research
- Exploring Retatrutide: A Triple-Hormone-Receptor Agonist for Obesity Management
- Exploring the Role of Retatrutide as a Triple-Hormone-Receptor Agonist for Obesity Management
- Exploring the Role of Retatrutide as a Triple-Hormone-Receptor Agonist in Obesity Treatment
- Exploring the Role of Retatrutide in Triple Hormone Receptor Activation
- Retatrutide's Impact on Gastric Emptying: Insights from Recent Research
- Understanding Adipocyte Differentiation and Lipolytic Function in Retatrutide Research
- Exploring the Role of Enteroendocrine Cells in Retatrutide Mechanisms
- Exploring Retatrutide: Insights from LY3437943 as a Triple Agonist for Metabolic Health
- Exploring Retatrutide: A New GLP-1 Injection for Metabolic Health
- Exploring Retatrutide: A New Era in GLP-1 Injection Therapy
- Exploring the Role of Retatrutide in Next Generation GLP-1 Therapies
- Retatrutide: A New Era in Diabetes Treatment with Triple-Action Mechanism
- Advancements in Retatrutide Research: The GLP-3R Designation Explained
- Advancements in Retatrutide Research: The Introduction of GLP-3R Designation
- Exploring Retatrutide: A Key Player Among Future GLP-1 Drugs
- Exploring Retatrutide: Implications of Triple Agonists in Metabolic Health
- Exploring Retatrutide's Triple Agonism at GLP-1R, GIPR, and GCGR